--- title: "Hong Kong stock movement: Progress in clinical trials of innovative drugs boosts the market, INSILICO's stock price soars 20.11%" type: "News" locale: "en" url: "https://longbridge.com/en/news/272223551.md" description: "INSILICO surged 20.11%; Yimaitong rose 14.17%, with a transaction volume of HKD 293 million; Brainstorm Aurora-B increased by 1.09%, with a transaction volume of HKD 271 million; Yidu Technology rose 10.15%, with a transaction volume of HKD 222 million; iFlytek Medical Technology increased by 5.89%, with a market value of HKD 12.5 billion" datetime: "2026-01-12T06:11:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/272223551.md) - [en](https://longbridge.com/en/news/272223551.md) - [zh-HK](https://longbridge.com/zh-HK/news/272223551.md) --- # Hong Kong stock movement: Progress in clinical trials of innovative drugs boosts the market, INSILICO's stock price soars 20.11% **Hong Kong Stock Movement** INSILICO surged 20.11%. Based on recent news, 1. On January 12, INSILICO announced that its innovative candidate drug Garutadustat completed the first subject dosing in the Phase IIa clinical trial. This drug aims to treat inflammatory bowel disease and is developed with the assistance of the company's proprietary artificial intelligence platform Pharma.AI, featuring a unique dual mechanism of anti-inflammatory activity and promoting intestinal barrier repair. This news boosted market confidence, driving the stock price significantly higher. 2. On January 12, INSILICO's Garutadustat received approval for its generic name from the United States Adopted Names Council. This move further enhanced market expectations for the drug's future commercialization prospects, propelling the stock price upward. 3. On January 12, after its listing in Hong Kong, INSILICO attracted attention and investment from high-profile investors including American pharmaceutical giant Eli Lilly, Tencent, and Temasek Holdings. The participation of these investors brought more market attention and financial support to the company, further driving the stock price up. The biotechnology industry has recently performed strongly, with broad prospects for AI technology applications. **Stocks with High Trading Volume in the Industry** Yimaitong rose 14.17%, with a trading volume of HKD 293 million, and no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. Brainstorm Aurora-B rose 1.09%. Based on recent key news: 1. On January 12, Brainstorm Aurora-B recorded large pre-market trades, with the transaction price 8.55% lower than the previous close, affecting stock price fluctuations. The trading amount was HKD 53.92 million, indicating increased market attention on this stock. Source: Economic Information Daily 2. On January 8, shareholders of Brainstorm Aurora-B deposited shares into HSBC Hong Kong, with a market value of HKD 742 million, accounting for 8.13%. This move may reflect shareholders' confidence in the company's future development, driving the stock price up. Source: Zhitong Finance 3. Brainstorm Aurora-B's interim results for the period ending June 30, 2025, showed a 92.82% year-on-year increase in revenue, but a 11.64% year-on-year increase in net loss, indicating complex performance that may affect investor sentiment. The Hong Kong stock market has recently experienced increased volatility and requires attention. Yidu Tech rose 10.15%, with a trading volume of HKD 222 million, and no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. **Stocks with High Market Capitalization in the Industry** iFlytek Medical Technology rose 5.89%. Based on recent key news: 1. On January 9, MiniMax surged over 100% on its first day of listing, igniting interest in artificial intelligence applications and driving iFlytek Medical Technology's stock price up. As a major player in the AI medical field, iFlytek Medical Technology benefited from policy support and industry catalysts, with its stock price rising 20.58%. Source: Zhitong Finance 2. On January 11, the capital market revalued AI companies, and iFlytek Medical Technology secured a national-level pilot base project, becoming the definers of medical AI acceptance. Competitors attended, and iFlytek Medical Technology stood at a new competitive starting point, benefiting from a rise in stock price. Source: Zhitong Finance 3. On January 9, OpenAI launched the ChatGPT Health feature, promoting the development of AI in the medical field. As the company with the widest coverage in the industry, iFlytek Medical Technology benefited from policy support and industry development, leading to an increase in stock price. Source: Zhitong Finance. The policy support for the AI medical field continues to strengthen ### Related Stocks - [03696.HK](https://longbridge.com/en/quote/03696.HK.md) - [02506.HK](https://longbridge.com/en/quote/02506.HK.md) - [06681.HK](https://longbridge.com/en/quote/06681.HK.md) ## Related News & Research - [BrainAurora Partners with DODR to Launch Cognitive Digital Therapeutics in Malaysia and Southeast Asia](https://longbridge.com/en/news/274921274.md) - [Some May Be Optimistic About Coloplast's (CPH:COLO B) Earnings](https://longbridge.com/en/news/287005062.md) - [InSilico Expands AI-Driven CNS Collaboration With Tenacia in USD94.75 Million Deal](https://longbridge.com/en/news/280541264.md) - [09:00 ETGenerative AI Leap: Insilico Medicine Nominates First Preclinical Candidate in the UAE](https://longbridge.com/en/news/284007341.md) - [InSilico Medicine Wins China IND Nod for AI-Discovered IPF Drug Rentosertib](https://longbridge.com/en/news/284467539.md)